Book chapter · 2022

Introduction to Quality of Life in Drug Development

Bellinda L. King‐Kallimanis, Lee W. Jones, Lynn Jackson Howie

Springer eBooks, 353–370 · Published 26 March 2022 · DOI 10.1007/978-3-030-84702-9_21

View at the publisherCite this paper

In brief

“Introduction to Quality of Life in Drug Development” is a 2022 book chapter by Bellinda L. King‐Kallimanis and 2 co-authors, published in Springer eBooks. OpenAlex counts 0 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
References
25
Authors
3

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

King‐Kallimanis, B. L., Jones, L. W., & Howie, L. J. (2022). Introduction to Quality of Life in Drug Development. Springer eBooks, 353–370. https://doi.org/10.1007/978-3-030-84702-9_21

MLA 9

King‐Kallimanis, Bellinda L., et al. “Introduction to Quality of Life in Drug Development.” Springer eBooks, 2022, pp. 353–370. https://doi.org/10.1007/978-3-030-84702-9_21.

Chicago

King‐Kallimanis, Bellinda L., Lee W. Jones, and Lynn Jackson Howie. 2022. “Introduction to Quality of Life in Drug Development.” Springer eBooks: 353–370. https://doi.org/10.1007/978-3-030-84702-9_21.

Harvard

King‐Kallimanis, B. L., Jones, L. W. and Howie, L. J. (2022) ‘Introduction to Quality of Life in Drug Development’, Springer eBooks, pp. 353–370. doi:10.1007/978-3-030-84702-9_21.

IEEE

B. L. King‐Kallimanis, L. W. Jones, and L. J. Howie, “Introduction to Quality of Life in Drug Development,” Springer eBooks, pp. 353–370, 2022, doi: 10.1007/978-3-030-84702-9_21.

BibTeX

@incollection{kingkallimanis2022introduction,
  title     = {{Introduction to Quality of Life in Drug Development}},
  author    = {King‐Kallimanis, Bellinda L. and Jones, Lee W. and Howie, Lynn Jackson},
  booktitle = {Springer eBooks},
  publisher = {Springer Nature},
  year      = {2022},
  pages     = {353--370},
  doi       = {10.1007/978-3-030-84702-9_21},
  url       = {https://doi.org/10.1007/978-3-030-84702-9_21}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life

  • quality of life
  • patient-reported outcomes
  • cancer clinical trials
  • drug development
  • regulatory requirements
  • FDA drug labeling
  • clinical trial endpoints
  • efficacy endpoints

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

King‐Kallimanis, B. L., Jones, L. W., & Howie, L. J. (2022). Introduction to Quality of Life in Drug Development. Springer eBooks, 353–370. https://doi.org/10.1007/978-3-030-84702-9_21

How many times has this paper been cited?

0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Bellinda L. King‐Kallimanis, Lee W. Jones, Lynn Jackson Howie.

What is the DOI of this paper?

10.1007/978-3-030-84702-9_21, permanently at https://doi.org/10.1007/978-3-030-84702-9_21. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.